SUPN
SUPN
NASDAQ · Pharmaceuticals

Supernus Pharmaceuticals Inc

Mid-Cap Stocks Pharmaceutical Stocks Healthcare Stocks
$47.64
+0.88 (+1.88%)
As of Aug 8, 9:59 PM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 10 83%
Hold 2 17%
Sell 0 0%
Price Target
Analyst Price Target +90.7% upside
Low Target $64.19
Average Target $90.83
High Target $118.96
Current Price $47.64
Current
$47.64
Target
$90.83
$64.19 $90.83 avg $118.96
Scenario Analysis
Bear Case
$64.19
34.7%
Low target
Base Case
$90.83
+90.7%
Avg target
Bull Case
$118.96
+149.7%
High target
Risk/Reward
4.3x
Highly favorable
Price in Context
52-Week High
$59.68
-20.2% from high
52-Week Low
$38.26
+24.5% from low
50-Day SMA
$49.76
-4.3% vs SMA
200-Day SMA
$43.00
+10.8% vs SMA
RSI (14)
59.9
Neutral
Target vs 52W High
$90.83
+52.2% vs high
Next Earnings Report
Aug 11, 2026
1d
tomorrow
EPS Est: $0.43
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
 Strong Buy 38 79% $1,330.33 +12.2%
RDY
Dr. Reddy's Laboratories
 Strong Sell 45 31% — +0.0%
JNJ
Johnson & Johnson
 Buy 31 71% $299.55 +15.5%
MRK
Merck & Co. Inc.
 Buy 36 69% $159.27 +23.9%
PFE
Pfizer Inc.
 Hold 36 39% $33.90 +26.7%
BMY
Bristol-Myers Squibb Co
 Hold 35 40% $174.50 +169.6%
RPRX
Royalty Pharma Plc- Cl A
 Strong Buy 16 88% $36.26 -36.1%
ZTS
Zoetis Inc
 Hold 24 54% $209.87 +188.8%